Porous implants as drug delivery vehicles to augment host tissue integration
Authors:
- 15 January 2008
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 22 (6) , 1684-1693
Abstract
The common premise of synthetic implants in the restoration of diseased tissues and organs is to use inert and solid materials. Here, a porous titanium implant was fabricated for the delivery of microencapsulated bioactive cues. Control‐released transforming growth factor‐β1 (TGF‐β1) promoted the proliferation and migration of human mesenchymal stem cells into porous implants in vitro. At 4 wk of implantation in the rabbit humerus, control‐released TGF‐βl from porous implants significantly increased bone‐to‐implant contact (BIC) by 96% and bone ingrowth by 50% over placebos. Control‐released 100 ng TGF‐β1 induced equivalent BIC and bone ingrowth to adsorbed 1 μg TGF‐β1, suggesting that controlled release is effective at 10‐fold less drug dose than adsorption. Histomorphometry, scanning electron microscopy, and microcomputed tomography showed that control‐released TGF‐β1 enhanced bone ingrowth in the implant's pores and surface. These findings suggest that solid prostheses can be transformed into porous implants to serve as drug delivery carriers, from which control‐released bioactive cues augment host tissue integration.— Clark, P. A., Moioli, E. K., Sumner, D. R., Mao, J. J. Porous implants as drug delivery vehicles to augment host tissue integration. FASEB J. 22, 1684–1693 (2008)Keywords
Funding Information
- National Institutes of Health (DE015391, EB02332)
This publication has 32 references indexed in Scilit:
- The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegrationBiomaterials, 2007
- Inhibition of osteogenic differentiation of human mesenchymal stem cellsWound Repair and Regeneration, 2007
- Interface Interactions of Osteoblasts with Structured Titanium and the Correlation between Physicochemical Characteristics and Cell Biological ParametersMacromolecular Bioscience, 2007
- Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineeringAdvanced Drug Delivery Reviews, 2007
- Transforming growth factor‐beta 1 (TGF‐β1) prevents the age‐dependent decrease in bone formation in human osteoblast/implant culturesJournal of Biomedical Materials Research Part A, 2005
- Modulation of bone ingrowth of rabbit femur titanium implants by in vivo axial micromechanical loadingJournal of Applied Physiology, 2005
- Functionalization of dental implant surfaces using adhesion moleculesJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2004
- Osteogenic protein‐1 enhances osseointegration of titanium implants coated with peri‐apatite in rabbit femoral defectJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2004
- Bone engineering by controlled delivery of osteoinductive molecules and cellsExpert Opinion on Biological Therapy, 2004
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991